| Literature DB >> 28391786 |
Jordi Río1, Cristina Auger2, Àlex Rovira2.
Abstract
MR imaging is the most sensitive tool for identifying lesions in patients with multiple sclerosis (MS). MR imaging has also acquired an essential role in the detection of complications arising from these treatments and in the assessment and prediction of efficacy. In the future, other radiological measures that have shown prognostic value may be incorporated within the models for predicting treatment response. This article examines the role of MR imaging as a prognostic tool in patients with MS and the recommendations that have been proposed in recent years to monitor patients who are treated with disease-modifying drugs.Entities:
Keywords: Interferon; MR imaging; Multiple sclerosis; Patient assessment; Relapsing-remitting multiple sclerosis; Scoring system; Treatment response
Mesh:
Year: 2017 PMID: 28391786 DOI: 10.1016/j.nic.2017.01.001
Source DB: PubMed Journal: Neuroimaging Clin N Am ISSN: 1052-5149 Impact factor: 2.264